Pregnancy Clinical Trials
A listing of Pregnancy medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
Found 1541 clinical trials
BIVV020 in Prevention and Treatment of Antibody-mediated Rejection (AMR)
Primary Objectives: Cohort A: To evaluate the efficacy of BIVV020 in prevention of AMR Cohort B: To evaluate the efficacy of BIVV020 in treatment of active AMR Secondary Objectives: To assess the overall efficacy of BIVV020 in prevention or treatment of AMR To characterize the safety and tolerability of BIVV020 …
- 16 views
- 25 Jan, 2023
- 20 locations
Healthy MY 3853-0007
="MsoPlainText">Medical history, vital signs, ECGs, physical examinations and pregnancy, drug, alcohol and tobacco screens will be performed. Blood and urine samples will also be obtained during this study.
- 745 views
- 09 Jun, 2020
- 1 location
Healthy OL 3426-0009
intramuscular injection. Vital signs, ECGs, physical examinations and pregnancy, drug and alcohol screens will be performed. Blood and urine samples will also be obtained during this study.
- 527 views
- 09 Jun, 2020
- 1 location
Dietary Omega-7 Palmitoleic Acid-Rich Oil on Lipoprotein Metabolism and Satiety in Adults
disease. Subjects not allergic to fish oil and fish products Females that are not pregnant and are not planning a pregnancy during the length of the study Design
- 193 views
- 23 Nov, 2020
- 1 location
Response to the HEPLISAV-B Hepatitis B Vaccine in Chronic Lymphocytic Leukemia (CLL) Patients that are Treatment Naive or Receiving Bruton s-tyrosine Kinase Inhibitor (BTK-I) Therapy
> Physical exam Blood tests Pregnancy test Visit 1: Participants will get blood drawn and the study vaccine. It will
- 67 views
- 09 Apr, 2019
- 1 location
Response to the SHINGRIX Varicella Zoster Virus (VZV) Vaccine in Chronic Lymphocytic Leukemia (CLL) Patients that are Treatment Naive or Receiving Bruton s-Tyrosine Kinase Inhibitor (BTK-I) Therapy
> At visit 1, participants may have a pregnancy test, blood test, or physical exam. Pregnant participants cannot be in the study. Eligible participants will get the
- 238 views
- 09 Apr, 2019
- 1 location
Ibrutinib, Fludarabine, and Pembrolizumab in High-Risk or Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
injected before the scan. Pregnancy test Phase 1 will be 12 weeks. Participants will take ibrutinib by mouth once a day. For weeks 5 and 9 they will also take fludarabine. It will be
- 359 views
- 23 Nov, 2020
- 1 location
Eosinophilic Esophagitis Research Study
The purpose of this study is to see if CC-93538 is safe and effective as a possible treatment for EoE. To do this, a comparison will be made between subjects who receive CC-93538 and subjects who receive a placebo (a ‘dummy treatment’ that looks like CC-93538 but contains no active …
- 0 views
- 14 Jan, 2022
- 1 location
Ascend-Nash: A Phase 2b, Randomized, Multi-Center, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of Crv431 In Adult Subjects With Nonalcoholic Steatohepatitis And Advanced Liver Fibrosis
Objectives:Primary: To evaluate the efficacy and safety of once daily (QD) 75 mg, 150 mg, and 225 mg doses of Rencofilstat compared to placebo control in subjects with biopsy-proven nonalcoholic steatohepatitis (NASH) and stage 2 liver fibrosis (F2) / stage 3 liver fibrosis (F3).Exploratory:To validate the use of a composite NASH …
- 0 views
- 29 Sep, 2022
- 1 location